|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.04 EUR | +0.48% |
|
+4.93% | -6.87% |
| 06-09 | Kymera Therapeutics Unlocks $20 Million Milestone After Dosing First Participant in KT-485 Phase 1 Trial | MT |
| 06-09 | SANOFI : Deutsche Bank remains its Buy rating | ZD |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 97.1 | +26.64% | 23 | ||||||
| 1,215.1 | +5.74% | 29 | ||||||
| 252.87 | +8.92% | 23 | ||||||
| 253.55 | +13.66% | 29 | ||||||
| 360.76 | +11.8% | 17 | ||||||
| 129.74 | +8.55% | 27 | ||||||
| 221.42 | +19.99% | 21 | ||||||
| 155.2 | +5.1% | 21 | ||||||
| 311.78 | +14.62% | 23 | ||||||
| 352.23 | +1.88% | 30 | ||||||
| 157.83 | +23.21% | 29 | ||||||
| 29.19 | +13.93% | 27 | ||||||
| 63.08 | +13.51% | 25 | ||||||
| 548.69 | +23.87% | 29 | ||||||
| 20.83 | +8.88% | 20 | ||||||
| 9,973.33 | +33.6% | 15 | ||||||
| 6,136.87 | +21.52% | 15 | ||||||
| 81.26 | +76.89% | 16 | ||||||
| 49.47 | +38.62% | 19 | ||||||
| 445.81 | +52.59% | 27 | ||||||
| Average | 1,042.81 | +21.18% | 23 | ||||||
| Weighted average by Cap. | 680.73 | +12.66% | 25 |
- Stock Market
- Stocks
- SAN Stock
- Sector Sanofi
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition